The treatment paradigm for genitourinary cancers is rapidly evolving, requiring clinicians to stay up to date with novel immunotherapeutic and targeted therapy approvals. This live webinar provides an in-depth look at the latest guidelines and clinical evidence in genitourinary cancer care, including bladder and prostate cancer. Tune in to hear experts share practical strategies for personalizing treatment decision-making, providing timely access to novel therapies, and multidisciplinary approaches to improve outcomes for patients in federal, public, and government health care settings.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/bladder-prostate-cancers-gu-cancers-personalized-approach-selecting
- Start Date: 2025-04-15 05:00:00
- End Date: 2025-04-15 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Aveo Pharmaceuticals - Amount: 2083.33 - Is Kind Support: False Source: Merck (Any division) - Amount: 16666.67 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest